Related Experiment Video
Updated: Dec 26, 2025

07:07
Creating Transient Cell Membrane Pores Using a Standard Inkjet Printer
Published on: March 16, 2012
39.3K
Recent advances in iNKT cell development
Kristin Hogquist1, Hristo Georgiev1
1Center for Immunology, University of Minnesota, Minneapolis, MN, 55455, USA.
F1000Research
|March 10, 2020
Summary
Invariant natural killer T (iNKT) cell development results in three subsets: NKT1, NKT2, and NKT17. T-cell receptor signal strength guides iNKT cell progenitors toward specific subsets for commitment and functionality.
Area of Science:
- Immunology
- Cell Biology
- Developmental Biology
Background:
- Recent studies identify three terminally differentiated murine invariant natural killer T (iNKT) cell subsets: NKT1, NKT2, and NKT17.
- The factors influencing subset commitment in iNKT cell progenitors remain largely unknown.
Purpose of the Study:
- To review recent findings on iNKT cell development, focusing on factors driving subset commitment.
- To discuss the identification of early iNKT progenitor cells and factors essential for their function.
Main Methods:
- Literature review of recent studies on iNKT cell development.
- Analysis of T-cell receptor signal strength as a driver of iNKT cell subset commitment.
- Discussion of factors supporting iNKT cell sustenance and functionality.
Main Results:
- T-cell receptor signal strength is a key factor steering iNKT cell progenitors toward specific differentiation pathways.
- Early progenitor cells can be identified, and factors for their sustenance and functionality are crucial.
- The majority of thymic iNKT cells are mature effector cells, not developing precursors.
Conclusions:
- Understanding the factors that drive iNKT cell subset commitment is critical for comprehending adaptive immunity.
- The differentiation pathways of iNKT cells are influenced by signal strength and progenitor cell characteristics.
- iNKT cells mature within the thymus, suggesting a primary role as effector cells in this organ.
Related Concept Videos
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K

